Art

J-GLOBAL ID：202002257693031698   Reference number：20A0848678

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

新規診断多発性骨髄腫に対するエロツズマブ+レナリドミドとデキサメタゾン:日本におけるランダム化非盲検第II相研究

Author (18)： Kubo Kohmei (Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan) ,  Hori Mitsuo (Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Japan) ,  Ohta Kensuke (Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan) ,  Ohta Kensuke (Hematology Ohta Clinic, Shinsaibashi, Osaka, Japan) ,  Handa Hiroshi (Department of Hematology, Gunma University Hospital, Maebashi, Japan) ,  Hatake Kiyohiko (Department of Lymphoma/Hematologic Malignancy Center, Mita Hospital, International University of Health and Welfare, Tokyo, Japan) ,  Matsumoto Morio (Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan) ,  Hagiwara Shotaro (Division of Hematology, Internal Medicine, National Center for Global Health and Medicine Hospital, Tokyo, Japan) ,  Hagiwara Shotaro (Department of Hematology, Tokyo Women’s Medical University, Tokyo, Japan) ,  Ohashi Kazuteru (Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan) ,  Nakaseko Chiaki (Department of Hematology, Chiba University Hospital, Chiba, Japan) ,  Nakaseko Chiaki (Department of Hematology, School of Medicine, International University of Health and Welfare, Narita, Japan) ,  Suzuki Kenshi (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan) ,  Ito Shigeki (Department of Clinical Oncology, Iwate Medical University Hospital, Morioka, Japan) ,  Kinoshita Gen (Bristol-Myers Squibb K.K., Tokyo, Japan) ,  Shelat Suresh G. (Bristol-Myers Squibb, Princeton, NJ, USA) ,  Miyoshi Masafumi (Bristol-Myers Squibb K.K., Tokyo, Japan) ,  Takezako Naoki (Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 111  Issue： 1  Page： 65-74  Publication year： Jan. 2020 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *multiple myeloma ,...
Semi thesaurus term： *Elotuzumab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0848678&from=J-GLOBAL&jstjournalNo=F0888A") }}

Author keywords (4)： Multiple myeloma ,  Newly diagnosed ,  Elotuzumab ,  Stem cell transplantation-ineligible

JST classification (3)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (2)： Dexamethasone ,  CC-5013

Terms in the title (10)： 診断 ,  多発性骨髄腫 ,  エロツズマブ ,  レナリドミド ,  デキサメタゾン ,  日本 ,  ランダム化 ,  盲 ,  第II相 ,  研究